2-Aminoadamantane | CAS 13074-39-0 - Request Quote
2-Aminoadamantane
| SZ CAT No: | SZ-A015024 |
| CAS No | 13074-39-0 |
| Mol.F. | C10H17N |
| Mol.Wt. | 151.3 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 10523-68-9 (HCl salt) ; 2015171-69-2 (HBr salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
2-Aminoadamantane is chemically (1R,3S,5r,7r)-adamantan-2-amine. 2-Aminoadamantane is supplied with detailed characterization data compliant with regulatory guideline. 2-Aminoadamantane can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Amantadine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 13074-39-0
Purchase 13074-39-0
Order 13074-39-0
Enquire 13074-39-0
price of 13074-39-0
13074-39-0 Supplier
13074-39-0 Manufacturer
13074-39-0 Exporter
buy high quality 2-Aminoadamantane
Purchase 2-Aminoadamantane
2-Aminoadamantane suppliers
2-Aminoadamantane manufacturers
2-Aminoadamantane price
Order 2-Aminoadamantane
Enquire 2-Aminoadamantane
2-Aminoadamantane cost
2-Aminoadamantane Supplier
2-Aminoadamantane Distributor
2-Aminoadamantane for Method Validation
Amantadine Reference Standard
2-Aminoadamantane for ANDA Filing
2-Aminoadamantane for Forced Degradation Studies
2-Aminoadamantane Identification Standards
2-Aminoadamantane for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


